Titre : | Comprehensive Cancer Centers : a relevant model in France ? |
Auteurs : | Olivier Exertier |
Type de document : | Mémoire |
Année de publication : | 2013 |
Description : | 62p. / ann. |
Langues: | Anglais |
Classement : | EHMBA13/ (Master EHESP Executive Health MBA (master of business administration)) |
Mots-clés : | Centre anti cancéreux ; Spécialisation ; Cancérologie ; Pôle activité ; Coopération interhospitalière ; Organisation hospitalière ; Malade ; France |
Résumé : | In 1990, the NCI initiated a new program in the USA called Comprehensive Cancer Centers to support the major American Cancer Centers. This dissertation aims to analyze if this model is relevant in France and how it has been implemented by INCa since 2010 thanks to the SIRIC program. After an historical presentation, this work develops a quantitative and qualitative analysis of the French Cancer Centers to identify and characterize the Comprehensive Cancer Centers at national level. The statistics collected (HopsiDiag, Unicancer, INCa...) show that a specific group of Cancer Centers can be identified in France. Our analysis exposes that Comprehensive Cancer Centers correspond to a rather homogenous reality in France with minimum standards. Their inputs (HR, medical means and finance) are above national average, as well as their outpus (patients treated, clinical research and scientific publications). Considering the resource based view, we find out that regarding their human and material resources, the French Comprehensive Cancer Centers have a slightly lower productivity than the other Cancer Centers in terms of care, a similar productivity for clinical trials, but a lot higher productivity for their scientific production. Comprehensive Cancer Centers are unique in the national healthcare landscape due to their high degree of specialization. They were pioneers in France by implementing new medical principles and organizations such as “Transdisciplinary research & translational medicine” and as a result, they represent a new kind of organization. However, a case analysis (Villejuif, Toulouse and other international experiences) demonstrates that it corresponds only to a second level of development for Cancer Centers. A third stage of strategy development consists in a growth outside the borders of the Comprehensive Cancer Center, leading to the creation of a new kind of bioclusters : Cancer Campus. |
Diplôme : | Master MBA Executive Health |
Plan de classement simplifié : | Master EHESP Executive Health (MBA) |
En ligne : | http://documentation.ehesp.fr/memoires/2013/ehmba/exertier.pdf |
Exemplaires (1)
Code-barres | Cote | Support | Localisation | Section | Disponibilité |
---|---|---|---|---|---|
080334 | EHMBA13/0003 | Mémoire | Rennes | Magasin | Empruntable Disponible |
Documents numériques (1)
ehmba/exertier URL |